We would like to inform you of the important Drug Recall on Norgestimate and Ethinyl Estradiol Tablets USP sent from Glenmark-Generics.
Glenmark-Generics is recalling seven (7) lots of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg. Glenmark Generics issued a voluntary, nationwide, consumer-level recall because of packaging error, where select blisters were rotated 180 degrees within the card, reversing the weekly tablet orientation and making the lot number and expiry date visible only in the outer pouch. Any blister for which the lot number and expiry date is not visible is subject to recall.
These tablets were manufactured and packaged by Glenmark Generics Ltd. India. and are distributed by Glenmark Generics Inc.USA. This product was distributed to wholesalers and retail pharmacies nationwide between September 21, 2011 and December 30, 2011.
Lot numbers of affected packs of Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.035 mg, 0.215 mg, 0.035 mg, 0.25 mg/0.035 mg, (Generic) are as follows:
NDC Lot Nos Expiration
68462-565-29 04110101 7/31/2013
04110106 7/31/2013
04110107 7/31/2013
04110114 8/31/2013
04110124 8/31/2013
04110129 8/31/2013
04110134 9/30/2013
Any adverse events that may be related to the use of these products should be reported to Glenmark Generics, Inc., USA at 1-(888) 721-7115 (8 AM to 5 PM Mon-Fri EST) or to FDA’s Med Watch Program either online, by regular mail or by fax.
Online: www.fda.gov/medwatch/report.htm
Regular Mail: Use postage-paid, pre-addresses Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm. Mail to the address on the pre-addressed form.
Fax: 1-800-FDA-0178
It's here! It's here! The Fall Cooperative Quarterly is here!
Many times, family planning gets pigeon holed into "women's health", which is why this edition of the Cooperative Quarterly is focused on men. Articles range from how men's masculinity beliefs can affect the healthcare they receive, tips from an in-depth study on how to create a male services program at a family planning clinic, educational materials with a strong male focus and the benefits of yoga for men. As always, there is a lot of information from our vendors too!
Enjoy.
Read the Fall 2009 Cooperative Quarterly
Read past newsletters
Click HERE to read our newsletter online!
Public Release Date: 12-October-2008
An extensive study of how the nursing profession has been portrayed in films over the last century has shown that unflattering stereotypes are becoming less common and nurses are now being portrayed in a more positive light.
Continue reading "Project Highlights Changing Face of Nurses in Films Over the Last 100 Years "
Public Release Date: 7-February-2008
On Wednesday, the Cincinnati-based Kroger announced that it will begin selling 30-day supplies of more than 300 generic prescription drugs, including birth control pills, at significant discounts at participating pharmacies nationwide, the Atlanta Journal-Constitution reports.
Continue reading "Kroger Launches Discount Drug Program, Includes Generic Birth Control"
Public Policy Alert: 27-December-2007
Title X Increased by 16.8 million dollars for fiscal year 2008!
Late last night, President Bush signed the Omnibus Appropriations Bill, which included a $16.8 million increase for the Title X family planning program. This is the third largest increase to the Title X program in twenty five years!
In addition, the bill level-funds (provides no increase to) abstinence only programs, putting an end to the previous link between Title X funding and abstinence-only funding.
Many thanks to each and every one of you for your hard work on this issue! Your phone calls and letters to your legislators clearly had an impact. Congratulations and best wishes for a happy, healthy and successful 2008!
For further information, visit www.nfprha.org or contact CFHC’s Public Policy Division at 213-386-5614.
Public Release Date: 30-November-2007
CAMBRIDGE, England -- A rapid point-of-care test for Chlamydia has demonstrated good accuracy compared with conventional tests, investigators here found.
Continue reading "Rapid Chlamydia Test Shows Promise for 'Test and Treat' Strategy"
Public Release Date: 19-November-2007
People with sexually transmitted infections are putting themselves at risk by buying treatments over the internet, according to new research by the University of East Anglia.
Less than a quarter of internet vendors gave information on potential side effects of their treatments. They also failed to say if their products would interfere with any prescription medicines that patients might be on, or if there might be harm to patients who were breastfeeding or pregnant. Equally, less than a quarter of vendors provided advice on how to avoid transmission and becoming re-infected.
Continue reading "Internet Remedies for STIs Pose Significant Public Health Hazard"
Public Release Date: 31-October-2007
"Medicaid's Role in Family Planning," Guttmacher Institute, Kaiser Family Foundation: The issue brief examines coverage provided by Medicaid for women of reproductive age at the national and state levels; the range of services covered as part of family planning; state-initiated family planning expansions and their impact in reducing abortions, and unintended pregnancies and births; and recent changes in Medicaid policy, including the federal Deficit Reduction Act of 2005.
Public Release Date: 24-July-2007
CHICAGO -- Medicare patients who couldn't read a physician's instructions, or who didn't understand what they read had a higher mortality rate than patients with adequate reading skills.
After adjusting for demographics, socioeconomic status, disability, and chronic conditions, patients with inadequate health literacy were 52% more likely to die during an average of 67.8 months of follow-up (P<0.001), according to a study reported in the July 23 issue of Archives of Internal Medicine.
Continue reading "Literacy Linked to Survival in Medicare Patients"